14Dec 2017

DIFFUSION WEIGHTED IMAGING IN PROSTATE CANCER A REVIEW.

  • Department of Radiology, Tongji Hospital, Tongji University School of Medicine, 389 XinCun Road, Putuo District, Shanghai 200065, PR China.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Diffusion Weighed Imaging (DWI) is a sequence of specific Magnetic Resonance Imaging (MRI) and software generated images from the data which uses the diffusion of water molecules to generate contrast in Magnetic Resonance images. It allows to guide the diffusion of water molecules non-invasively, particularly in biological tissue in vivo. DWI is routinely used in MRI for the evaluation of prostate cancer. In this article, we review the general view of the Diffusion Weighted Imaging, its advantages over being used; and its limitations which can be developed into technique to improve the accuracy of Magnetic Resonance Imaging in prostate cancer. The correlation of Diffusion Weighted Imaging with b value and Gleason Score in prostate cancer for prognosis of the disease.

1.? Jie C, Rongbo L, Ping T. The value of diffusion-weighted imaging in the detection of prostate cancer: A meta-analysis. Eur Radiol. 2014;24(8):1929?41.
  1. Steenbergen P, Haustermans K, Lerut E, Oyen R, De Wever L, Van Den Bergh L, et al. Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation. Radiother Oncol [Internet]. 2015;115(2):186?90. Available from: http://dx.doi.org/10.1016/j.radonc.2015.04.012
  2. Hectors SJ, Besa C, Wagner M, Jajamovich GH, Haines GK, Lewis S, et al. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness. J Magn Reson Imaging [Internet]. 2017;1?13. Available from: http://doi.wiley.com/10.1002/jmri.25631
  3. Kim CK, Park BK, Kim B. Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. Vol. 194, American Journal of Roentgenology. 2010. p. 1461?9.
  4. Shigemura K, Yamanaka N, Yamashita M. Can diffusion-weighted magnetic resonance imaging predict a high gleason score of prostate cancer? Korean J Urol. 2013;54(4):234?8.
  5. Bittencourt LK, Barentsz JO, De Miranda LCD, Gasparetto EL. Prostate MRI: Diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason grades than TRUS-guided biopsies in peripheral zone tumours. Eur Radiol. 2012;22(2):468?75.
  6. Sinnott M, Falzarano SM, Hernandez A V., Jones JS, Klein EA, Zhou M, et al. Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy. Prostate. 2012;72(11):1179?86.
  7. Yagci AB, Ozari N, Aybek Z, Duzcan E. The value of diffusion-weighted MRI for prostate cancer detection and localization. Diagnostic Interv Radiol [Internet]. 2011;17(2):130?4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20694948
  8. Tan CH, Wang J, Kundra V. Diffusion weighted imaging in prostate cancer. Eur Radiol. 2011;21(3):593?603.
  9. Kajihara H, Hayashida Y, Murakami R, Katahira K, Nishimura R, Hamada Y, et al. Usefulness of Diffusion-Weighted Imaging in the Localization of Prostate Cancer. Int J Radiat Oncol Biol Phys. 2009;74(2):399?403.
  10. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S. Prostate cancer screening: The clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging. 2007;25(1):146?52.
  11. Haider MA, Van Der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. Am J Roentgenol. 2007;189(2):323?8.
  12. Shimofusa R, Fujimoto H, Akamata H, Motoori K, Yamamoto S, Ueda T, et al. Diffusion-Weighted Imaging of Prostate Cancer. J Comput Assist Tomogr [Internet]. 2005;29(2):149?53. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00004728-200503000-00001
  13. Lim HK, Kim JK, Kim KA, Cho KS. Prostate cancer: Apparent diffusion coefficient map with T2-weighted images for detection - A multireader study. Int Braz J Urol. 2009;35(1):100?100.
  14. Gibbs P, Pickles MD, Turnbull LW. Diffusion imaging of the prostate at 3.0 tesla. Invest Radiol. 2006;41(2):185?8.
  15. Hoeks CM, Futterer JJ, Somford DM, van Oort IM, Huisman H, Barentsz JO. [Multiparametric MRI for prostate cancer screening]. Ned Tijdschr Geneeskd [Internet]. 2009;153:B487. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20003566
  16. Maas MC, F?tterer JJ, Scheenen TWJ. Quantitative Evaluation of Computed High b Value Diffusion-Weighted Magnetic Resonance Imaging of the Prostate. Invest Radiol [Internet]. 2013;48(11):779?86. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00004424-201311000-00004
  17. Agarwal HK, Mertan F V., Sankineni S, Bernardo M, Senegas J, Keupp J, et al. Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone. J Magn Reson Imaging. 2017;45(1):125?31.
  18. Barbieri S, Br?nnimann M, Boxler S, Vermathen P, Thoeny HC. Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI. Eur Radiol. 2017;27(4):1547?55.
  19. Epstein JI. An Update of the Gleason Grading System. J Urol. 2010;183(2):433?40.
  20. Gofrit ON, Zorn KC, Taxy JB, Lin S, Zagaja GP, Steinberg GD, et al. Predicting the Risk of Patients With Biopsy Gleason Score 6 to Harbor a Higher Grade Cancer. J Urol. 2007;178(5):1925?8.
  21. Pinthus JH, Witkos M, Fleshner NE, Sweet J, Evans A, Jewett MA, et al. Prostate Cancers Scored as Gleason 6 on Prostate Biopsy are Frequently Gleason 7 Tumors at Radical Prostatectomy: Implication on Outcome. J Urol. 2006;176(3):979?84.
  22. Dong F, Jones JS, Stephenson AJ, Magi-Galluzzi C, Reuther AM, Klein EA. Prostate Cancer Volume at Biopsy Predicts Clinically Significant Upgrading. J Urol. 2008;179(3):896?900.
  23. Hong SK, Han BK, Lee ST, Kim SS, Min KE, Jeong SJ, et al. Prediction of Gleason score upgrading in low-risk prostate cancers diagnosed via multi (???12)-core prostate biopsy. World J Urol. 2009;27(2):271?6.
  24. Sarici H, Telli O, Yigitbasi O, Ekici M, Ozgur BC, Yuceturk CN, et al. Predictors of Gleason score upgrading in patients with prostate biopsy Gleason score ???6. J Can Urol Assoc. 2014;8(5?6).
  25. Elabbady AA, Khedr MM. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of gleason score. Eur Urol. 2006;49(1):49?53.
  26. Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, et al. Biopsy Core Number Represents One of Foremost Predictors of Clinically Significant Gleason Sum Upgrading in Patients With Low-risk Prostate Cancer. Urology. 2009;73(5):1087?91.
  27. Park SY, Oh YT, Jung DC, Cho NH, Choi YD, Rha KH, et al. Diffusion-weighted imaging predicts upgrading of Gleason score in biopsy-proven low grade prostate cancers. BJU Int. 2017;119(1):57?66.
  28. Choi YJ, Kim JK, Kim N, Kim KW, Choi EK, Cho K-S. Functional MR Imaging of Prostate Cancer. RadioGraphics [Internet]. 2007;27(1):63?75. Available from: http://pubs.rsna.org/doi/10.1148/rg.271065078
  29. Kitajima K, Kaji Y, Kuroda K, Sugimura K. High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. Magn Reson Med Sci [Internet]. 2008;7(2):93?9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18603841
  30. Shinmoto H, Oshio K, Tanimoto A, Higuchi N, Okuda S, Kuribayashi S, et al. Biexponential apparent diffusion coefficients in prostate cancer. Magn Reson Imaging. 2009;27(3):355?9.
  31. Mulkern R V., Barnes AS, Haker SJ, Hung YP, Rybicki FJ, Maier SE, et al. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging. 2006;24(5):563?8.
  32. Niendorf T, Dijkhuizen RM, Norris DG, van Lookeren Campagne M, Nicolay K. Biexponential diffusion attenuation in various states of brain tissue: implications for diffusion-weighted imaging. Magn Reson Med. 1996;36(6):847?57.
  33. Maier SE, Bogner P, Bajzik G, Mamata H, Mamata Y, Repa I, et al. Normal brain and brain tumor: multicomponent apparent diffusion coefficient line scan imaging. Radiology. 2001;219(3):842?9.
  34. Woo S, Suh CH, Kim SY, Cho JY, Kim SH. Head-To-Head Comparison Between High- and Standard-b-Value DWI for Detecting Prostate Cancer: A Systematic Review and Meta-Analysis. Am J Roentgenol [Internet]. 2017;1?10. Available from: http://www.ajronline.org/doi/10.2214/AJR.17.18480
  35. Merisaari H, Toivonen J, Pesola M, Taimen P, Bostr?m PJ, Pahikkala T, et al. Diffusion-weighted imaging of prostate cancer: Effect of b-value distribution on repeatability and cancer characterization. Magn Reson Imaging [Internet]. 2015;33(10):1212?8. Available from: http://dx.doi.org/10.1016/j.mri.2015.07.004
  36. Valerio M, Zini C, Fierro D, Giura F, Colarieti A, Giuliani A, et al. 3T multiparametric MRI of the prostate: Does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone? Eur J Radiol. 2016;85(4):790?4.
  37. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: Applications and challenges in oncology. Am J Roentgenol. 2007;188(6):1622?35.
  38. Padhani AR, Liu G, Mu-Koh D, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations. Neoplasia [Internet]. 2009;11(2):102?25. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1476558609800249
  39. Kim CK, Park BK, Han JJ, Kang TW, Lee HM. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results. J Comput Assist Tomogr. 2007;31(3):449?54.

[Awash Shrestha and Wang Pei Jun. (2017); DIFFUSION WEIGHTED IMAGING IN PROSTATE CANCER A REVIEW. Int. J. of Adv. Res. 5 (Dec). 550-554] (ISSN 2320-5407). www.journalijar.com

Prof. Wang Pei Jun
Tongji University

DOI:

Article DOI: 10.21474/IJAR01/5992      
DOI URL: https://dx.doi.org/10.21474/IJAR01/5992

Download Full Paper

Download PDF No. of Downloads: 2 | No. of Views: 67